- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| Mo | Vertical Aerospace Doubles Flight Test Capacity With Final Prototype | 189 | Final prototype to expand flight test capacity and enable public demonstrations Initial all-electric testing ahead of hybrid-electric flights in 2026 Vertical progresses towards full... ► Artikel lesen | ||
| Mo | Novocure to Present at 44th Annual J.P. Morgan Healthcare Conference | 148 | Novocure (NASDAQ: NVCR) announced today that management will participate in the 44th Annual J.P. Morgan Healthcare Conference taking place in San Francisco on January 12-15, 2026. Frank Leonard, Chief... ► Artikel lesen | ||
| Mo | Kolibri Global Energy Inc. Provides Operations Update | 148 | Kolibri Global Energy Inc. (the "Company" or "Kolibri") (TSX: KEI, NASDAQ: KGEI) is pleased to provide an operations update on its latest wells in its Tishomingo field in Oklahoma.
FIELD UPDATE... ► Artikel lesen | ||
| Mo | Access Advance LLC: Hisense tritt dem HEVC Advance Patentpool bei | 165 | Access Advance LLC, weltweit führend im Bereich der Lizenzierung von Video-Codec-Patentpools, gab heute bekannt, dass Hisense Group Holdings Co., Ltd. dem HEVC Advance Patent Pool als Lizenznehmer... ► Artikel lesen | ||
| Mo | KalVista Pharmaceuticals, Inc.: KalVista Pharmaceuticals Announces Approval of EKTERLY (sebetralstat) in Japan, First and Only Oral On-demand Treatment for Hereditary Angioedema | 193 | KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing approval for EKTERLY (sebetralstat)... ► Artikel lesen | ||
| Mo | Havas Reports the Progress of Transactions Under Its Current Share Buyback Program | 246 | Regulatory News:
Havas N.V. (EURONEXT: HAVAS) hereby reports transaction details related to the €50 million buyback program as communicated on May 28, 2025.
From December 15, 2025, up to and... ► Artikel lesen | ||
| Mo | Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson's Disease | 179 | Zambon Biotech, a specialized biotech company part of the Zambon group that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the... ► Artikel lesen | ||
| Mo | Zambon Biotech meldet erste Dosisverabreichung der klinischen Phase-3b-Studie ADIP zu IPX203 bei Parkinson | 208 | Zambon Biotech ein spezialisiertes Biotechnologie-Unternehmen der Zambon-Unternehmensgruppe, das den Aufbau eines wissenschaftlich fundierten und wirtschaftlich tragfähigen Portfolios innovativer... ► Artikel lesen | ||
| Mo | Axelspace Corporation: Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch | 150 | Axelspace Corporation ("Axelspace"), a leading microsatellite company committed to making "Space within Your Reach," is pleased to announce a multi-launch agreement (MLA) with Exolaunch, a global... ► Artikel lesen | ||
| Mo | Omdia: Global Cloud Infrastructure Spending Hits $102.6 Billion, up 25% in Q3 2025 | 210 | According to new research from Omdia, global spending on cloud infrastructure services reached $102.6 billion in Q3 2025, representing 25% year-on-year growth. Market momentum remained stable, marking... ► Artikel lesen | ||
| Mo | viagogo: The Most Iconic Moments From Lily Allen, Lewis Capaldi, Katy Perry and Drake Revealed in Year in Live Experiences Report | 263 | From Lily Allen creating the ultimate diss album, Lewis Capaldi beating Drake and Kendrick, to Katy Perry's space adventure impacting her ticket sales a new report unlocks fans favourite moments in... ► Artikel lesen | ||
| Mo | Merck KGaA: Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor | 273 | First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER study In MANEUVER, pimicotinib significantly improved objective response rate... ► Artikel lesen | ||
| Mo | Merck: Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor | 285 | First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER study In MANEUVER, pimicotinib significantly improved objective response rate... ► Artikel lesen | ||
| Mo | KKR Launches European Rail Leasing Platform with Green Mobility Partners | 264 | Strategic partnership to scale newly established locomotive and train leasing company into a leading European rail leasing platform
Green Mobility Partners ("GMP"), a Vienna-based electric locomotive... ► Artikel lesen | ||
| Mo | Incyte Japan Announces Approval of Zynyz (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer | 223 | Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based... ► Artikel lesen | ||
| Mo | Incyte Japan Announces Approval of Minjuvi (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma | 212 | Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi (tafasitamab) in combination with rituximab and lenalidomide for adult... ► Artikel lesen | ||
| Mo | GBC AG Analyst Coverage Report on Mexedia S.p.A. Società Benefit Completed and Published | 159 | Regulatory News:
Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN IT0005450819) ("Mexedia" or the "Company") informs that the analyst coverage report prepared by GBC AG one of... ► Artikel lesen | ||
| Mo | Cloudfresh Wins 2025 EMEA GitLab Partner of the Year Award for Emerging Markets in Eastern Europe and Israel | 188 | Cloudfresh, a certified GitLab Select and Professional Services Partner and a global leader in delivering multi-vendor cloud solutions, announced today that it has received the 2025 EMEA GitLab Partner... ► Artikel lesen | ||
| Mo | Coty Appoints Markus Strobel Executive Chairman and Interim CEO | 470 | Regulatory News:
Coty Inc. (NYSE: COTY) (Paris: COTY) ("Coty" or "the Company") today announced that Markus Strobel will become Executive Chairman of the Board and Interim Chief Executive Officer... ► Artikel lesen | ||
| Mo | JAB Insurance to Enter UK Life and Pension Market With Acquisition of Utmost Group's Life and Pensions Business | 196 | JAB Insurance today announced that it has entered into a definitive agreement to acquire from Utmost Group plc its Life and Pensions business ("ULP"), a UK life and pensions platform with more than... ► Artikel lesen | ||
| Mo | GenSight Biologics S.A.: GenSight Biologics Announces the Granting of Compassionate Use Authorization (CUA/AAC) for GS010/LUMEVOQ in France | 302 | French medicines agency ANSM has granted authorization for named patient early access program for GS010/LUMEVOQ, a gene therapy indicated for the treatment of ND4-LHON.
Regulatory News:
GenSight... ► Artikel lesen | ||
| Mo | Innate Pharma SA: Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025 | 233 | Regulatory News:
Pursuant to the article L. 233-8 II of the French "Code de Commerce" and the article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or "AMF") General... ► Artikel lesen | ||
| Mo | Textron Inc.: Textron Aviation Defense sichert sich ersten Auftrag zur Bereitstellung des integrierten Trainingssystems Beechcraft T-6 Texan II für Japan | 339 | Textron Aviation Defense LLC, ein Unternehmen der Textron Inc. (NYSE:TXT), hat heute den ersten Liefervertrag für das integrierte Trainingssystem Beechcraft T-6JP Texan II an die japanische Luftverteidigungskräfte... ► Artikel lesen | ||
| So | Clearwater Analytics to Be Acquired for $8.4 Billion by Permira and Warburg Pincus, Supported by Francisco Partners and With Participation From Temasek | 609 | Stockholders will receive $24.55 per share Clearwater Analytics (NYSE: CWAN) ("CWAN" or the "Company"), announced that it has entered into a definitive agreement to be acquired in a transaction... ► Artikel lesen | ||
| Fr | Rithm Property Trust Inc. Announces Reverse Stock Split | 70 | NEW YORK--(BUSINESS WIRE)--Rithm Property Trust Inc. (NYSE: RPT, "RPT" or the "Company") today announced that its Board of Directors unanimously approved a one-for-six reverse stock split (the "Reverse... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .